Neuropathic pain is estimated to affect 3%--‐4.5% of the worldwide population and is associated with significant loss of productivity and the development of mood and substance use development of mood and substance use disorders. Chronic neuropathic pain is difficult to treat with medication and deep brain stimulation (DBS) targeting subcortical structures (periaqueductal gray or thalamic nuclei) has been investigated for refractory neuropathic pain. However, recent work indicates that stimulation of the dorsal anterior cingulate cortex (dACC) may be a new potential neuromodulatory target, given its role in affective processing of pain.